MedTrace Logo

Effect of a Health Pathway for People With Persistent Symptoms Covid-19

NCT05787366 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-05-06

No results posted yet for this study

Summary

People with persistent symptoms of covid-19 have increased needs for needs for management of their overall health (physical, psychological and social). Persistent covid-19 symptoms have a negative impact on quality of life. By proposing a follow-up and an intervention on the reduction of these symptoms, the symptoms, the study will improve quality of life.

Conditions

Interventions

OTHER

usual care and follow-up by a nurse

follow-up by a nurse and referral to a specialist(s) according to symptoms

OTHER

Personalized Multifactorial Intervention (IMP)

The content of the intervention is defined according to the result of the initial assessment in relation to the person's needs and the nature of his or her persistent symptoms. The patient, depending on his or her needs, may choose to participate in the following workshops : * Knowledge of the disease and specific management, (led by the nurse) * Covid-19 and anxiety/depression, (psychologist) * Fatigue and adapted physical activities (video capsules) * Covid-long and social link (professional and voluntary activities...) (social worker and/or nurse) * The Recovery Café aims to provide a space for patients to listen to each other and share their experiences around themes related to the different dimensions of recovery: medical and psychological, economic, professional, social and existential.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Frédéric ROCHE, PhD · CHU de Saint Etienne

  • Bienvenu BONGUE, phD · Jean Monnet University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2025-09-12
Completion
2026-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05787366 on ClinicalTrials.gov